Profile
Gregory J.
Mossinghoff was the founder of Integrated Oncology Solutions, Inc. (founded in 2006) and Novolipid, Inc. (founded in 2010) where he held the titles of President & Chief Executive Officer.
He is also the founder of Tavros Therapeutics, Inc. Mr. Mossinghoff's former jobs include President, Chief Business Officer & Director at Inspire Pharmaceuticals, Inc. (1998-2005), Executive Vice President & Chief Business Officer at Zoion Pharma, Inc. (2010-2015), and Secretary & Chief Business Officer at G1 Therapeutics, Inc. (2015-2018).
Mr. Mossinghoff received his undergraduate degree from the University of Virginia and his MBA from George Mason University.
Gregory J. Mossinghoff active positions
| Companies | Position | Start |
|---|---|---|
Tavros Therapeutics, Inc.
Tavros Therapeutics, Inc. BiotechnologyHealth Technology Develops functional and computational genomics platform for oncology | Founder | - |
Former positions of Gregory J. Mossinghoff
| Companies | Position | End |
|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 2017-12-31 |
Zoion Pharma, Inc.
Zoion Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for veterinary disorders | Corporate Officer/Principal | 2014-12-31 |
Novolipid, Inc.
Novolipid, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drug products | Chief Executive Officer | 2012-12-31 |
Integrated Oncology Solutions, Inc. | Chief Executive Officer | 2009-12-31 |
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | President | 2004-12-31 |
Training of Gregory J. Mossinghoff
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
Integrated Oncology Solutions, Inc. | |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Mason University
George Mason University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Zoion Pharma, Inc.
Zoion Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for veterinary disorders | Health Technology |
Novolipid, Inc.
Novolipid, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drug products | Health Technology |
Tavros Therapeutics, Inc.
Tavros Therapeutics, Inc. BiotechnologyHealth Technology Develops functional and computational genomics platform for oncology | Health Technology |
- Stock Market
- Insiders
- Gregory J. Mossinghoff
















